Palestine Investment Bank P.L.C. (PEX:PIBC)
1.140
+0.050 (4.59%)
At close: Jul 31, 2025
Regulus Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 285.99 | 252.87 | 265.99 | 324.58 | 244.79 | Upgrade |
Investment Securities | 7.89 | 11.98 | 17 | 17.32 | 13.97 | Upgrade |
Trading Asset Securities | 2.73 | 3.86 | 5.12 | 8.47 | 17.56 | Upgrade |
Total Investments | 10.62 | 15.85 | 22.12 | 25.79 | 31.54 | Upgrade |
Gross Loans | 449.12 | 458.93 | 394.52 | 326.43 | 301.28 | Upgrade |
Allowance for Loan Losses | -20.96 | -14.64 | -9.32 | -7.76 | -5.21 | Upgrade |
Other Adjustments to Gross Loans | -4.79 | -3.74 | -2.83 | -1.96 | -1.16 | Upgrade |
Net Loans | 423.37 | 440.55 | 382.37 | 316.71 | 294.91 | Upgrade |
Property, Plant & Equipment | 29.23 | 27.53 | 26.53 | 26.7 | 27.56 | Upgrade |
Other Intangible Assets | 2.49 | 1.96 | 1.67 | 1.24 | 1.38 | Upgrade |
Accrued Interest Receivable | 1.95 | 2.11 | 1.75 | 1.66 | 1.46 | Upgrade |
Other Receivables | 1.51 | 4.99 | 2.08 | 0.96 | 4.78 | Upgrade |
Restricted Cash | 39.05 | 41.31 | 39.95 | 37.12 | 30.62 | Upgrade |
Other Current Assets | 4.74 | 2.45 | 1.9 | 1.86 | 2.71 | Upgrade |
Long-Term Deferred Tax Assets | 3.2 | 2.13 | 1.45 | 1.34 | 0.91 | Upgrade |
Other Long-Term Assets | 1.07 | 0.5 | 0.49 | 0.54 | 0.52 | Upgrade |
Total Assets | 803.22 | 792.25 | 746.3 | 738.5 | 641.18 | Upgrade |
Accounts Payable | 5.48 | 4.75 | 5.43 | 3.51 | 2.82 | Upgrade |
Accrued Expenses | 0.55 | 0.51 | 0.46 | 0.25 | 0.29 | Upgrade |
Interest Bearing Deposits | 404.08 | 365.91 | 347.99 | 351.94 | 305.96 | Upgrade |
Non-Interest Bearing Deposits | 229.35 | 261.29 | 241.53 | 228.19 | 191.83 | Upgrade |
Total Deposits | 633.43 | 627.2 | 589.53 | 580.12 | 497.79 | Upgrade |
Short-Term Borrowings | - | - | 0.18 | 1.37 | 0.7 | Upgrade |
Current Portion of Long-Term Debt | - | - | - | 1 | 1 | Upgrade |
Current Portion of Leases | 0.2 | 0.21 | 0.34 | 0.33 | 0.33 | Upgrade |
Current Income Taxes Payable | 4.73 | 4.22 | 2.55 | 1.47 | 1.11 | Upgrade |
Accrued Interest Payable | 1.77 | 2.23 | 1.48 | 1.24 | 1.05 | Upgrade |
Other Current Liabilities | 31.09 | 29.62 | 25.12 | 35.16 | 26.45 | Upgrade |
Long-Term Debt | 1.07 | 0.24 | 0.85 | 1.41 | 0.75 | Upgrade |
Long-Term Leases | 0.69 | 0.37 | 0.61 | 1.04 | 1.43 | Upgrade |
Long-Term Unearned Revenue | 0.79 | 0.95 | 1.19 | 1.2 | 1.23 | Upgrade |
Pension & Post-Retirement Benefits | 5.17 | 4.39 | 3.93 | 3.61 | 3.46 | Upgrade |
Long-Term Deferred Tax Liabilities | 1.01 | 1.01 | 1.01 | 0.57 | 0.57 | Upgrade |
Other Long-Term Liabilities | 12.37 | 11.97 | 10.24 | 3.6 | 3.35 | Upgrade |
Total Liabilities | 698.35 | 687.66 | 642.93 | 635.88 | 542.33 | Upgrade |
Common Stock | 80 | 78 | 78 | 78 | 78 | Upgrade |
Retained Earnings | 22.16 | 23.76 | 22.63 | 21.44 | 17.67 | Upgrade |
Comprehensive Income & Other | 2.71 | 2.82 | 2.74 | 3.19 | 3.18 | Upgrade |
Shareholders' Equity | 104.88 | 104.59 | 103.37 | 102.63 | 98.85 | Upgrade |
Total Liabilities & Equity | 803.22 | 792.25 | 746.3 | 738.5 | 641.18 | Upgrade |
Total Debt | 1.95 | 0.82 | 1.99 | 5.15 | 4.21 | Upgrade |
Net Cash (Debt) | 286.76 | 255.92 | 269.12 | 327.9 | 258.15 | Upgrade |
Net Cash Growth | 12.05% | -4.90% | -17.93% | 27.02% | 36.76% | Upgrade |
Net Cash Per Share | 3.58 | 3.20 | 3.36 | 4.10 | 3.23 | Upgrade |
Filing Date Shares Outstanding | 80 | 80 | 80 | 80 | 80 | Upgrade |
Total Common Shares Outstanding | 80 | 80 | 80 | 80 | 80 | Upgrade |
Book Value Per Share | 1.31 | 1.31 | 1.29 | 1.28 | 1.24 | Upgrade |
Tangible Book Value | 102.39 | 102.63 | 101.69 | 101.38 | 97.47 | Upgrade |
Tangible Book Value Per Share | 1.28 | 1.28 | 1.27 | 1.27 | 1.22 | Upgrade |
Updated Nov 17, 2024. Source: S&P Global Market Intelligence. Banks template. Financial Sources.